Adynovate
1 known investors
Find your way into Adynovate
Sign up to see every warm intro you have to Adynovate
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Adynovate team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
The site presents ADYNOVATE, a PEGylated recombinant antihemophilic Factor VIII injectable used to treat and control bleeding in adults and children with hemophilia A. It provides prescribing and safety information for patients and healthcare providers.
Investors · 1
Frequently asked questions
- What does Adynovate do?
- The site presents ADYNOVATE, a PEGylated recombinant antihemophilic Factor VIII injectable used to treat and control bleeding in adults and children with hemophilia A. It provides prescribing and safety information for patients and healthcare providers.
- Who are Adynovate's investors?
- Adynovate's investors include HEALTHCARE ROYALTY PARTNERS.